Fact CheckerSign in

NCT07656922Recruiting

Scapular Muscle Activation and Shoulder Performance in Migraine

INVESTIGATION OF SCAPULAR MUSCLE ACTIVATION AND SHOULDER PERFORMANCE IN INDIVIDUALS WITH MIGRAINE

Source: ClinicalTrials.gov · Last updated 18 Jun 2026

Brief summary (registry, in English)

Migraine is a significant health problem due to its high prevalence and substantial contribution to disability. Individuals with migraine have been reported to exhibit myofascial trigger points, increased pain sensitivity, and altered muscle activation patterns, particularly in the trapezius muscles. As the upper and middle trapezius muscles play critical roles in scapular stability and movement, alterations in these muscles may affect scapular orientation and upper extremity function. However, studies investigating the relationship between trapezius muscle activation, scapular orientation, and upper extremity performance in individuals with migraine are limited. Therefore, this study aimed to compare trapezius muscle activation, scapular orientation, and upper extremity performance between individuals with and without migraine. We hypothesized that individuals with migraine would exhibit altered upper and middle trapezius muscle activation, impaired scapular orientation, and reduced upper extremity performance compared with healthy controls.

Status (registry)
Recruiting
Study type
Observational
Enrollment
50 (estimated)
First submitted
15 Jun 2026
Start date
Apr 2026
Primary completion date
Jul 2026
Lead sponsor
Ankara Yildirim Beyazıt University
Diseases
Migraine
NCT number
NCT07656922

What you commit to

  • Study type: Observational
  • Planned participants: 50
  • From Apr 2026 to the primary completion date, Jul 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Receiving physiotherapy or rehabilitation for migraine or the cervical, thoracic, or upper extremity regions within the past 6 months

Other illness

  • Presence of other types of headache disorders
  • History of trauma, fracture, or surgery involving the cranio-cervical region, scapular region, or upper extremity
  • Presence of neurological or inflammatory rheumatic diseases
  • Presence of psychiatric disorders
  • Cognitive impairment affecting the understanding of test instructions

Who the study is looking for

  • Aged 18-55 years
  • Diagnosed with migraine by a neurologist according to the ICHD-3 criteria
  • Experiencing at least 3 migraine attacks per month
  • Willing to participate and provide written informed consent

Age in the registry: 18 years to 55 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Ankara Yıldırım Beyazıt University
Coordinator of this site? Confirm its status
AnkaraTurkey (Türkiye)Recruiting

This page is information, not medical advice. Discuss any trial with your doctor.